Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments
Biogen Inc.: Biogen and Stoke Therapeutics Enter into Collaborat…
Feb 18, 2025
finanznachrichten.de
Biogen to invest $2 billion in RTP, open new factory in 2025
Biogen to invest $2 billion in RTP, open new factory in 2025
7 months ago
wral.com
Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Conference, Nov-10-2025 11
Transcript : Biogen Inc. Presents at Wedbush Rewind ASN 2025 Confe…
4 months ago
zonebourse.com
Biogen Inc.: Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024
Biogen Inc.: Biogen Announces Late Breaker and New Data Presentatio…
Oct 22, 2024
finanznachrichten.de
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentations of Clinical Data from Studies of Zorevunersen for the Potential Treatment of Dravet Syndrome at the 36th International Epilepsy Congress
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
6 months ago
finanznachrichten.de
Biogen's Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease with No Targeted Treatment Options
Biogen's Litifilimab Receives FDA Breakthrough Therapy Designatio…
1 month ago
marketscreener.com
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
Biogen Inc.: Biogen and Stoke Therapeutics Announce Presentat…
8 months ago
finanznachrichten.de
Biogen Gets U.S., European Reviews of Higher-Dose Spinraza
Jan 23, 2025
marketscreener.com
In dramatic turn, Biogen seeks FDA approval for experimental Alzheim…
Oct 22, 2019
goodmorningamerica.com
Biogen | LinkedIn
11 months ago
linkedin.com
Biogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Tre…
8 months ago
finanznachrichten.de
Biogen Inc.: LEQEMBI IQLIK(lecanemab-irmb) Subcutane…
5 months ago
finanznachrichten.de
1:32
U.S. approval of Biogen Alzheimer's drug sends shares soaring, haile…
Jun 7, 2021
ReutersJulie Steenhuysen,Deena Beasley
0:47
Biogen Alzheimer's drug closer to approval with U.S. FDA staff backi…
5 months ago
ReutersDeena Beasley,Manojna Maddipatla
Careers | Biogen
Aug 2, 2018
biogen.com
US FDA approves Eisai, Biogen Alzheimer's drug
Jan 6, 2023
gmanetwork.com
Biogen Inc.: LEQEMBI (lecanemab) IV Maintenance Dosing for the Tre…
5 months ago
finanznachrichten.de
Biogen Inc.: Biogen to Acquire Alcyone Therapeutics, Expanding …
5 months ago
finanznachrichten.de
Biogen Inc.: Biogen and Stoke Therapeutics Present Data at the 3…
Feb 9, 2025
finanznachrichten.de
Biogen Licenses Global Rights To Develop, Commercialize SPINRAZ…
Jan 4, 2022
nasdaq.com
Biogen Inc.: LEQEMBI (Lecanemab) Approved for the Treatment of Alz…
5 months ago
finanznachrichten.de
Biogen CEO Sees New Chapter in Fight Against Alzheimer's
Jun 8, 2021
Bloomberg.comJohn Tozzi
1:58
Biogen shares soar on landmark Alzheimer's data, lift rivals
Sep 28, 2022
ReutersNatalie Grover,Manas Mishra
Biogen Inc.: Leqembi? (lecanemab) is the First Medicine that Slows Pr…
11 months ago
finanznachrichten.de
1:01
Biogen shares tank on scrapping Alzheimer trials
Mar 22, 2019
ReutersJulie Steenhuysen,Takashi Umekawa
0:25
Biogen seeks FDA approval for experimental Alzheimer's drug
Oct 22, 2019
ABC NewsErin Schumaker
1:12
First patient receives controversial Biogen Alzheimer’s drug
Jun 16, 2021
ReutersDeena Beasley
1:51
FDA approves first Alzheimer’s drug in nearly 20 years despite controv…
Jun 7, 2021
newsnationnow.com
Biogen Inc.: Dapirolizumab Pegol Phase 3 Data in SLE Presented at …
3 months ago
finanznachrichten.de
See more videos
Static thumbnail place holder